GGrantIndex
← Leaderboards

Thomas Frederick Newton

University Of California Los Angeles

$18,826,829
Attributed
$18,826,829
Total exposure
51
Grants
39
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY200516
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$18,826,829 · 51

By mechanism

R01$4,229,739 · 3
M01$3,770,515 · 31
R25$2,501,136 · 2
P50$2,478,965 · 2
R42$1,138,445 · 2
R21$986,283 · 3

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchMethamphetaminePharmaceutical PreparationsGrantPlacebosResearch PersonnelFundingCocaineBaseLaboratoriesSelf AdministrationParticipantClinical TrialsCravingVolunteerDependenceUnited States National Institutes Of HealthEvaluationAddictionDouble-Blind MethodTreatment EffectDrug AbuseDosePrograms

Grant awards (98)

Complementary Combination Therapy for Cocaine Dependence$383,314
R01 · FY2016 · DA · contact PI
Complementary Combination Therapy for Cocaine Dependence$387,187
R01 · FY2015 · DA · contact PI
Clinical Research Education for Drug Abuse Professionals$247,048
R25 · FY2015 · DA · contact PI
Triple Re-uptake Inhibitor, SKL 10406, as a New Treatment for Alcohol Dependence$139,899
R42 · FY2015 · AA · contact PI
Clinical Research Education for Drug Abuse Professionals$247,142
R25 · FY2014 · DA · contact PI
Carisbamate Treatment for Alcohol Dependence$139,300
R42 · FY2014 · AA · contact PI
Carisbamate Treatment for Alcohol Dependence$752,317
R42 · FY2013 · AA · contact PI
Clinical Research Education for Drug Abuse Professionals$222,516
R25 · FY2013 · DA · contact PI
Human Laboratory Studies$182,893
P50 · FY2013 · DA · contact PI
Carisbamate Treatment for Alcohol Dependence$106,929
R42 · FY2013 · AA · contact PI
An ACE Inhibitor as a Treatment for Methamphetamine Dependence$368,515
R01 · FY2012 · DA · contact PI
Clinical Research Education for Drug Abuse Professionals$247,341
R25 · FY2012 · DA · contact PI
Human Laboratory Studies$155,360
P50 · FY2012 · DA · contact PI
An ACE Inhibitor as a Treatment for Methamphetamine Dependence$368,515
R01 · FY2011 · DA · contact PI
Clinical Research Education for Drug Abuse Professionals$252,950
R25 · FY2011 · DA · contact PI
Human Laboratory Studies$151,546
P50 · FY2011 · DA · contact PI
AN ACE INHIBITOR AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE$43,929
M01 · FY2011 · RR · contact PI
THE EFFECTS OF DOXAZOSIN ON THE CARDIOVASCULAR AND SUBJECTIVE EFFECTS OF COCAINE$10,686
M01 · FY2011 · RR · contact PI
N-ACETYLCYSTEINE AS A POTENTIAL TREATMENT FOR METHAMPHETAMINE DEPENDENCE$5,936
M01 · FY2011 · RR · contact PI
An ACE Inhibitor as a Treatment for Methamphetamine Dependence$379,913
R01 · FY2010 · DA · contact PI
N-acetylcysteine as a Potential Treatment for Methamphetamine Dependence$192,062
R21 · FY2010 · DA · contact PI
Assess of Stress Effects in Methamphetamine Dependence$177,389
K24 · FY2010 · DA · contact PI
Human Laboratory Studies$168,423
P50 · FY2010 · DA · contact PI
AN ACE INHIBITOR AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE$33,954
M01 · FY2010 · RR · contact PI
LABORATORY MODELS OF COCAINE SELF ADMINISTRATION$26,705
M01 · FY2010 · RR · contact PI
An ACE Inhibitor as a Treatment for Methamphetamine Dependence$383,750
R01 · FY2009 · DA · contact PI
Trials of Medications for Stimulant Abuse Research Plan$270,563
P50 · FY2009 · DA · contact PI
N-acetylcysteine as a Potential Treatment for Methamphetamine Dependence$229,920
R21 · FY2009 · DA · contact PI
Human Laboratory Studies$179,340
P50 · FY2009 · DA · contact PI
Assess of Stress Effects in Methamphetamine Dependence$177,389
K24 · FY2009 · DA · contact PI
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION MODAFINIL EFFECTS$127,723
P20 · FY2009 · DA · contact PI
METHAMPHETAMINE DEPENDENCE: A NOVEL LABORATORY MODEL$398,796
M01 · FY2008 · RR · contact PI
An ACE Inhibitor as a Treatment for Methamphetamine Dependence$383,750
R01 · FY2008 · DA · contact PI
Trials of Medications for Stimulant Abuse Research Plan$379,148
P50 · FY2008 · DA · contact PI
Laboratory Models of Cocaine Self-Administration$356,587
R01 · FY2008 · DA · contact PI
ASSESSMENT OF GVG FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE$342,224
M01 · FY2008 · RR · contact PI
LABORATORY MODELS OF COCAINE SELF ADMINISTRATION$274,135
M01 · FY2008 · RR · contact PI
MODAFINIL AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE: INITIAL SAFETY, SUBJ$144,732
M01 · FY2008 · RR · contact PI
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION MODAFINIL EFFECTS$117,902
P20 · FY2008 · DA · contact PI
EFFECTS OF CHRONIC METHAMPHETAMINE USE ON SLEEP$97,676
M01 · FY2008 · RR · contact PI
PHARMACOLOGICAL MANIPULATION OF PSYCHOSOCIAL STRESS$356
M01 · FY2008 · RR · contact PI
Trials of Medications for Stimulant Abuse Research Plan$395,977
P50 · FY2007 · DA · contact PI
Laboratory Models of Cocaine Self-Administration$366,235
R01 · FY2007 · DA · contact PI
PERINDOPRIL - METHAMPHETAMINE INTERACTION STUDY$212,246
M01 · FY2007 · RR · contact PI
NIDA-1 P50 DA 018185: DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF R$195,418
M01 · FY2007 · RR · contact PI
Cycloserine Enhancement of Extinction Learning$154,000
R21 · FY2007 · DA · contact PI
LABORATORY MODELS OF COCAINE SELF ADMINISTRATION$137,720
M01 · FY2007 · RR · contact PI
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION: MODAFINIL EFFECTS$137,559
P20 · FY2007 · DA · contact PI
Assess of Stress Effects in Methamphetamine Dependence$124,200
K24 · FY2007 · DA · contact PI
Laboratory Models of Cocaine Self-Administration$88,550
R01 · FY2007 · DA · contact PI
ASSESSMENT OF GVG FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE$41,213
M01 · FY2007 · RR · contact PI
PHARMACOLOGICAL MANIPULATION OF PSYCHOSOCIAL STRESS$32,970
M01 · FY2007 · RR · contact PI
PHASE I, DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMEN$15,455
M01 · FY2007 · RR · contact PI
NEUROPSYCHOLOGICAL AND AFFECTIVE SEQUELAE OF 5-HT DEPLETION IN MDMA USERS$343
M01 · FY2007 · RR · contact PI
Laboratory Models of Cocaine Self-Administration$377,173
R01 · FY2006 · DA · contact PI
Clinical Research Education for Drug Abuse Professionals$309,597
R25 · FY2006 · DA · contact PI
Trials of Medications for Stimulant Abuse Research Plan$301,075
P50 · FY2006 · DA · contact PI
DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMENT OF POTENTIAL INTERACTIONS BETWEEN$245,836
M01 · FY2006 · RR · contact PI
PERINDOPRIL - METHAMPHETAMINE INTERACTION STUDY$227,819
M01 · FY2006 · RR · contact PI
NIDA-1 P50 DA 018185: DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF R$219,009
M01 · FY2006 · RR · contact PI
PHASE I, DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMEN$143,738
M01 · FY2006 · RR · contact PI
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION: MODAFINIL EFFECTS$139,306
P20 · FY2006 · DA · contact PI
Assess of Stress Effects in Methamphetamine Dependence$124,200
K24 · FY2006 · DA · contact PI
Perindopril-Methamphetamine Interaction Study$103,468
R21 · FY2006 · DA · contact PI
PHARMACOLOGICAL MANIPULATION OF PSYCHOSOCIAL STRESS$801
M01 · FY2006 · RR · contact PI
Laboratory Models of Cocaine Self-Administration$386,250
R01 · FY2005 · DA
Clinical Research Education for Drug Abuse Professionals$308,053
R25 · FY2005 · DA
Perindopril-Methamphetamine Interaction Study$154,333
R21 · FY2005 · DA
Assess of Stress Effects in Methamphetamine Dependence$124,200
K24 · FY2005 · DA
DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMENT OF POTENTIAL INTERACTIONS BETWEEN$82,579
M01 · FY2005 · RR
PHASE I, DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMEN$50,241
M01 · FY2005 · RR
PERINDOPRIL - METHAMPHETAMINE INTERACTION STUDY$14,726
M01 · FY2005 · RR
NEUROPSYCHOLOGICAL AND AFFECTIVE SEQUELAE OF 5-HT DEPLETION IN MDMA USERS$2,021
M01 · FY2005 · RR
Trials of Medications for Stimulant Abuse Research Plan$294,640
P50 · FY2004 · DA
Clinical Research Education for Drug Abuse Professionals$245,697
R25 · FY2004 · DA
Assessment of Potential Interactions Between Intravenous Methamphetamine and...$125,246
M01 · FY2004 · RR
Safety Assessment of Interaction btwn Cocaine and Amanta$118,151
M01 · FY2004 · RR
Double-Blind, Placebo Controlled Assessment of Potential Interactions Between...$101,506
M01 · FY2004 · RR
Study of the Relationships Among Serotonin, Neuropsych$7,913
M01 · FY2004 · RR
Clinical Research Education for Drug Abuse Professionals$244,242
R25 · FY2003 · DA
POSTDOCTORAL INTERDISCIPLINARY HIV-AIDS$171,054
T32 · FY2003 · MH
BRAIN CHANGES IN DRUG DEPENDENCE--CLINICAL IMPLICATIONS$167,648
K08 · FY2003 · DA
Perindopril-Methamphetamine Interaction Study$152,500
R21 · FY2003 · DA
Clinical Research Education for Drug Abuse Professionals$176,550
R25 · FY2002 · DA
BRAIN CHANGES IN DRUG DEPENDENCE--CLINICAL IMPLICATIONS$167,648
K08 · FY2002 · DA
POSTDOCTORAL INTERDISCIPLINARY HIV-AIDS$138,865
T32 · FY2002 · MH
SAFETY EVALUATION OF COCAINE LISURIDE INTERACTION$207,266
M01 · FY2001 · RR
BRAIN CHANGES IN DRUG DEPENDENCE--CLINICAL IMPLICATIONS$167,648
K08 · FY2001 · DA
POSTDOCTORAL INTERDISCIPLINARY HIV-AIDS$88,740
T32 · FY2001 · MH
CHALLENGE STUDY FOR ANTI-COCAINE ANTIBODIES$0
U19 · FY2001 · DA
CLINICAL TRIAL OPERATIONS$800,000
N01 · FY2000 · DA
CHALLENGE STUDY FOR ANTI-COCAINE ANTIBODIES$408,465
U19 · FY2000 · DA
SAFETY EVALUATION OF COCAINE LISURIDE INTERACTION$207,266
M01 · FY2000 · RR
BRAIN CHANGES IN DRUG DEPENDENCE--CLINICAL IMPLICATIONS$167,648
K08 · FY2000 · DA
POSTDOCTORAL INTERDISCIPLINARY HIV-AIDS$144,162
T32 · FY2000 · MH
CLINICAL TRIAL OPERATIONS$50,000
N01 · FY2000 · DA
SAFETY EVALUATION OF COCAINE LISURIDE INTERACTION$1,903
M01 · FY2000 · RR
CLINICAL TRIAL OPERATIONS$0
N01 · FY2000 · DA